 |
Introduction |
Dry eye associated with Sjögren's syndrome (SS dry eye) is
often more severe than non-Sjögren dry eye (non-SS dry
eye).1-3 Rose bengal staining, fluorescein staining,
impression cytology, and brush cytology show greater changes in SS dry
eye owing to a lack of both basic tearing and reflex tearing resulting
from lacrimal gland destruction by infiltrating lymphocytes, which is
the hallmark of deteriorating clinical conditions.1-5
Accumulated knowledge in the past decade has demonstrated the
importance of tear components such as epidermal growth factor (EGF) and
vitamin A in the regulation of proliferation, differentiation, and
maturation of the ocular surface epithelium.6-11 A
deficiency of these components can disrupt the normal proliferation and
maturation process of the epithelium. In non-SS dry eye, tear
components are supplied to the ocular surface through occasional reflex
tears. Thus, the problems associated with the complete depletion of
essential tear components are not as expected in non-SS dry eye, where
only a slight alteration of the ocular surface is
observed.12 However in SS dry eye, tear components are
lacking to the extent that the integrity of the ocular surface is
compromised, resulting in the disruption of the ocular surface
epithelium.2 4 5
In 1984 Fox et al reported the beneficial
effects of autologous serum application to dry eye in Sjögren's
syndrome.13 The rationale for their observation was based
upon the fact that vitamins or growth factors present in tears are also
present in serum. The application of autologous serum offers an
advantage over the simple use of artificial tears which lack such
essential components.14 Our recent experience with
frequent use of autologous serum in the reconstruction of the ocular
surface in severe dry eye such as ocular pemphigoid or Stevens-Johnson
syndrome supports the concept that the lack of biologically active tear
components can be replaced by autologous serum
application.15 16
The present study was designed to determine the efficacy and
safety of autologous serum application in the treatment of epithelial disorders associated with SS dry eye. The stability of the serum was
assessed by measuring the concentration of EGF, TGF-
, and vitamin
A in fresh serum samples, and after preservation in the freezer
(
20°C) and refrigerator (4°C) for up to 3 months. In a clinical
trial, diluted serum solutions (20% serum, 80% saline) were prepared
from venepunctured whole blood of SS patients, and various subjective
and objective clinical variables were analysed. Used bottles were
collected at the end of the study to test for possible contamination.
An in vitro study was also performed in order to determine the
effects of serum on mucin (MUC-1) expression in cultured conjunctival
cells as a possible therapeutic mechanism of serum.
 |
Materials and methods |
PREPARATION OF AUTOLOGOUS SERUM AND ITS APPLICATION TO DRY EYE
Tears contain essential components for the ocular surface such as
EGF, vitamin A, TGF-
, fibronectin, and various other cytokines. Since these components are also found in serum, we formulated artificial tears by diluting serum obtained from SS patients after informed consent was obtained. A total of 40 ml of blood was procured by venepuncture and centrifuged for 5 minutes at 1500 rpm. The serum
was carefully separated in a sterile manner and diluted by saline to
20%. The final preparation was aliquoted into 5 ml bottles with
ultraviolet light protection since vitamin A is easily degraded by
light. Patients were instructed to keep the bottle in a dark and cool
place, such as a refrigerator, while in use with the rest being stored
in a freezer until required. Serum drops were applied 6-10 times a day
in addition to the old regimen of frequent preservative-free artificial
tears, highly viscous hyaluronic acid (Hyalein, Santen Pharmaceutical
Co, Osaka, Japan) four times daily, and the use of special dry eye
glasses for added humidity. These glasses maintained the moisture level
around the eye at 40-80%, depending on the ambient humidity, while
the 0.3% hyaluronic acid offered additional
lubrication.17 Patients were instructed to use autologous
serum (diluted to 20% with saline), 6-10 times a day for 4 weeks and
vital staining of the ocular surface was compared before and after treatment.
MEASUREMENT OF ESSENTIAL TEAR COMPONENTS
The concentration of EGF, vitamin A, and TGF-
18 in
preserved serum (n=10) were measured under the following conditions; (1) immediately after preparation, (2) after 1 week and 1 month of
preservation in the refrigerator (4°C), (3) after 1 month and 3 months of preservation in the freezer (
20°C). The biological activity of the cytokines or vitamin A were not measured in this study.
EGF was measured by the homologous radioimmunoassay (RIA) method
as previously described by Hirata and Orth.19 Vitamin A was measured by high pressure liquid chromatography (HPLC) as reported
by Katsui.20 TGF-
was measured by the human TGF-
1 sandwich enzyme immunoassay technique (Quantikine, R & D systems, Minneapolis, MN, USA) according to the protocol by the manufacturer.
TEAR EVALUATION
To evaluate tear dynamics, the Schirmer test with or without
topical anaesthesia was performed, while maximum tear production was
evaluated by the Schirmer test with nasal stimulation. This test
measures the maximal tear secretion from the ipsilateral eye. Briefly,
the patients were checked by the simple Schirmer test for 5 minutes
without topical anaesthesia.5 Then a cotton swab was
inserted into the patient's nasal cavity towards the entrance of the
ethmoid sinus. The Schirmer strip of paper was placed on the
conjunctival sac as with the ordinary Schirmer test for 5 minutes while
the cotton swab was kept in place. The final measurement of tear
production was performed on an alternative day and performed in the
same manner as the ordinary Schirmer test by measuring the wet length
of the test strip. Values of less than 10 mm with nasal stimulation is
an indicator of severe loss of tear production.21
OCULAR SURFACE EVALUATION
The ocular surface was examined by the double staining
method. Two µl of preservative-free solution consisting of 1% rose bengal and 1% fluorescein dye were applied to the conjunctival sac.22 The intensity of rose bengal staining was recorded
in the temporal and nasal conjunctiva and the cornea, each graded on a
scale of 0 to 3 points. Thus, the maximum score obtained from the
staining of one eye is 9. Fluorescein staining was also rated from 0 to
9, but only in the cornea. Statistical analysis was performed using the
Wilcoxon signed rank test.
In three patients, impression cytology was performed before serum
application and 1 month after application by a method developed by
Tseng in order to evaluate squamous metaplasia.23
RECRUITMENT OF SS DRY EYE PATIENTS
The diagnosis of dry eye was made based on the following three
criteria as previously reported: (1) symptoms of dry eye, (2) abnormalities of tear dynamics determined by Schirmer test (5 mm),
clearance test (8×), cotton thread test (10 mm),24 and tear break up time (BUT, 5 seconds),25 (3) abnormalities
of ocular surface determined by rose bengal (>3+) or fluorescein vital
staining (>3+).2 25 When patients met all three
criteria, they were diagnosed as "definite dry eye". The vital
staining was done using a fixed concentration and volume of dye in
order to obtain stable results.
Overall subjective comfort was checked by a questionnaire using a face
score which consists of nine faces, each showing a different
expression. Patients were asked to select which face best describes the
current condition of their eyes
for example, a very sad face describes
a bad condition of the ocular surface (No 9 on face score) and a happy
face describes no irritation to the ocular surface (No 1 on face score)
(Fig 1). Specific subjective complaints were divided into nine
categories with maximum scores of 9 and a minimum of 1, which were
graded by patients before, 2, and 4 weeks after the
treatment.26
Among the dry eye patients, the diagnosis of SS type dry eye was made
according to a modified version of Fox and Saito's
criteria27 and decreased reflex tearing.21
Patients with severe ocular complaints were recruited for this study
since patients with only slight subjective complaints lacked the
motivation to enrol in the study that required drawing blood by
venepuncture. A total of 12 SS dry eye patients were recruited and the
explanation of using autologous serum was given followed by written
informed consent. All enrolled patients had Schirmer test values with
nasal stimulation of less than 10 mm.
BACTERIAL CULTURE OF USED AUTOLOGOUS SERUM
Since preservatives were not added to serum solutions,
contamination during patient use was of concern. Cultures of the
remaining serum following patient use was performed for possible
contamination by bacteria or fungi.
FLOW CYTOMETRIC ANALYSIS OF MUC-1 ON CULTURED
CONJUNCTIVAL EPITHELIUM
A conjunctival epithelial cell line, CCL.20.2 (American Type
Culture Collection [ATCC], Rockville, MD, USA) was cultured in medium
199 (Gibco, Grand Island, NY, USA) supplemented with 10% fetal calf
serum (FCS) (Gibco), 100 units/ml penicillin, and 100 units/ml
streptomycin. In this study, the medium was changed to FCS-free medium
1 day before the experiments, and then cells were treated with two
different concentrations of human serum (15%, 30%) for 24 hours.
Normal human serum was separated from a healthy volunteer. The handling
of human tissue samples complied with the tenets of the Declaration of
Helsinki, and proper consent and approval were obtained before all
experiments where appropriate.
Cells were reacted with anti-MUC-1 core protein antibody (Novocastra
Laboratories Ltd, Newcastle, Tyne) for 1 hour at 4°C. After washing,
the cells were reacted with fluorescein labelled goat anti-mouse (lgG + lgM) antibody (Tago, Burlingame, CA, USA), and then analysed by an
EPICS-XL flow cytometer (Courter Electronics, Hialeah, FL, USA).
 |
Results |
PRESERVATION OF SERUM COMPONENTS
Serum preparation was obtained from 10 normal healthy volunteers
(five females and five males, average age of 45.5 (SD 12.3) years) and
the concentration of EGF, vitamin A, and TGF-
1 were measured at the
beginning, 1 week, and 1 month after preservation in the refrigerator
(
4°C). The mean (SD) value of the three variables were 0.52 (0.08)
ng/ml for EGF, 45.5 (19.1) µg/dl for vitamin A and 33.2 (6.8) ng/ml
for TGF-
1 at the initial period, and did not significantly change
during the 1 month preservation period (Table 1).
The effect of longer preservation in the freezer (
20°C) was
examined in another group of 10 healthy volunteers (eight females, two
males, average age of 55.5 (13.5) years). The above components were
measured on the initial day, at 1 month, and 3 months after preservation in the freezer. The concentration of each component did
not change during the 3 month preservation period (Table 2).
EFFECT OF AUTOLOGOUS SERUM FOR THE TREATMENT OF SS DRY EYE
The face score was 7.9 (0.9) before treatment, which improved to
5.3 (2.3) at 2 weeks and 5.2 (5.1) at 4 weeks with serum application
(p<0.05).
Rose bengal and fluorescein scores before and after treatment are shown
in Table 3. There was a significant improvement in both scores after
serum application; however, no significant change in BUT scores was
observed.
BACTERIAL CULTURE OF STORED SERUM
Patients were instructed that meticulous attention should be paid
to the possible contamination of bottles since no preservatives were
added to the serum. However, none of the collected samples were culture
positive for either bacteria or fungi (n=12 at 2 weeks of preservation).
MUC-1 EXPRESSION
CCL.20.2 expressed a significant amount of MUC-1 spontaneously,
compared with the negative control performed with an isotype matched
unrelated mAb. Application of human serum increased the expression of
MUC-1 on CCL.20.2 in a dose dependent manner (Table 4).
CASE REPORT
A 71 year old woman had been suffering from Sjögren's syndrome
over the past 10 years. The patient had no ocular abnormalities except
for severe dry eye and senile cataract. The Schirmer test result was 5 mm in the right and 4 mm in the left eye, with tear clearance rate of
2× in both eyes. The calculated tear function index of each eye was
10 in the right and 8 in the left. The Schirmer test with nasal
stimulation was also less than 5 mm in both eyes.
Although the patient was treated with a combination of various
treatments such as preservative-free eye drops, eye glasses with
moisture inserts, and 0.3% hyaluronic acid, rose bengal and fluorescein staining was prominent (Fig 2A, B). Her corrected visual
acuity was also impaired to 20/50 in the right eye and 20/200 in the
left eye. Impression cytology showed a lack of goblet cells and severe
squamous metaplasia in the bulbar conjunctiva by impression cytology
(Fig 2C). The patient was placed on autologous serum application 10 times a day.

View larger version (53K):
[in this window]
[in a new window]
|
Figure 2
Slit lamp photographs stained by rose bengal and
fluorescein of the left eye of the patients described (A, B). Note the
corneal epithelium was deeply stained by fluorescein. Impression
cytology of the bulbar conjunctiva in patients with Sjögren's
syndrome (C) stained by PAS staining. There are no goblet cells
observed. The epithelial cells are enlarged showing the squamous
metaplasia.
|
|
Subjective complaints were severe before treatment (face score of 9)
which decreased to 6 after 4 weeks treatment. Rose bengal and
fluorescein staining improved dramatically after serum application (Fig
3A, B). Impression cytology showed the appearance of goblet cells and
improvement of squamous metaplasia (Fig 3C).

View larger version (58K):
[in this window]
[in a new window]
|
Figure 3
Slit lamp photographs stained by rose bengal and
fluorescein of the left eye of the patients after the autologous serum
treatment for 1 month. (A, B) Note the corneal epithelium dramatically
improved. Impression cytology of the bulbar conjunctiva in patients
with Sjögren's syndrome also improved (C). Goblet cells are observed
with smaller epithelial cells.
|
|
 |
Discussion |
This study demonstrated a clear benefit of using autologous serum
for the treatment of dry eye associated with Sjögren's syndrome. We
postulated that the theoretical background of using serum is the
supplementation of important tear components that may be lacking in
severe dry eyes. We measured EGF, vitamin A, and TGF-
concentrations in serum and found that these components can be supplied to the ocular
surface by this method. Furthermore, it was confirmed that the
autologous serum samples can be preserved for more than 1 month in the
refrigerator and more than 3 months in the freezer.
Dry eye is now categorised into two types; one is dry eye associated
with tear deficiency, and the other is associated with increased tear
evaporation.28 The first type of dry eye is further divided to Sjögren's dry eye and non-Sjögren's dry eye. In
non-Sjögren's dry eye, only basic tearing is affected and the ocular
surface alteration is minimal, although subjective complaints are often similar to SS dry eye.2 12 In SS dry eye, increased vital staining, squamous metaplasia observed by impression cytology and
increased lymphocyte infiltration of the ocular surface observed by
brush cytology are the major alterations compared with the non-SS dry
eye.2 29
Fundamental treatment for SS dry eye is yet to be developed. There is
no medication that stimulates secretion of the patient's own tears;
therefore, the alleviation of symptoms is the major aim of currently
available treatments.28 30 Basically, dry eye is thought
to be caused by desiccation, drying of the ocular surface, and it is
important to use all possible measures to keep the ocular surface wet.
This includes methods such as increased blinking, placing the video
display terminal in a low position so that patients can look down and
narrow their palpebral fissure, the use of dry eye glasses to increase
the environmental humidity, and the frequent use of artificial
tears.17 31-35 These treatments are effective to some
extent, but the squamous metaplasia observed on the ocular surface of
SS dry eye patients cannot be reversed by these conventional treatments.
Recent research has shown the importance of tear components for
maintaining a healthy ocular surface epithelium. There are many
essential factors present in tears such as EGF and vitamin A.6 7 9 11 Ohashi et al
reported that EGF is present in basic and reflex tears followed
by several studies that demonstrated that EGF is effective for the
acceleration of corneal epithelial proliferation.8 The
concentration of EGF in tears is reported to be 0.7-8.1 ng/ml in
reflex tears and 1.9-9.7 ng/ml in non-reflex tears, which is higher
than EGF in serum which ranges around 0.5 ng/ml. In contrast, the
amounts of retinol in human tear has been reported by Speek
et al36 to be 0.4-10.6 ng/ml.
Since the concentration of retinol in serum is around 55 µg/ml, serum
contains more than 1000 times the amount available in tears. When
vitamin A is lacking, the epithelium tends to undergo squamous
metaplasia.37 38 Application of serum may provide higher
levels of retinol necessary in pathological conditions.
Tear TGF-
is somewhat more controversial. Wilson
et al 39 reported in 1991 that
there were no mRNA of TGF-
1 in the lacrimal gland, but Gupta
et al 18 reported that it is
present around the level of 10 ng/ml in human tear. The TGF-
concentration in human serum is around 50 ng/ml which is five times
higher than in tears. TGF-
is believed to control epithelial
proliferation, and to maintain cells in an undifferentiated state such
as the induction of the basic keratins in epidermal cells.
The concentration of biologically active molecules is different in
serum and tear fluids. However, since many of the essential components
in tears are also present in serum, the use of serum as a tear
substitute for the maintenance of the ocular surface seems feasible.
There is always the possibility that serum may contain components that
are detrimental to the ocular surface. TGF-
, for example, is known
to have antiproliferative effects, and high concentrations of TGF-
may suppress wound healing of the ocular surface epithelium. This was
one of the reasons for using a diluted solution of serum in order to
maintain TGF-
levels comparable with tears. Dilution also has the
benefit of obtaining larger amounts of serum eye drops from one sample.
Further study is necessary to determine the most effective
concentration of serum.
It is interesting to note that the components in serum were stable in
the refrigerator for 1 month and in the freezer for 3 months. In serum,
there are many proteins such as albumin or globulin which can protect
the degradation of important cytokines. Although the mechanism is
unknown, the prolonged preservation of these components in serum makes
autologous application clinically possible. With this knowledge, we
obtained 40 ml of blood from SS patients every 3 months. A 40 ml sample
of venous blood from SS patients is enough to last for at least 3 months. Twenty ml of serum can be obtained from 40 ml of whole blood,
while diluting 1:5 with saline provides 100 ml serum solution. If each
eye drop is 50 µl, 2000 drops can be obtained from 100 ml. SS dry eye
patients use a maximum of 20 drops a day (10 times for each eye), thus 2000 drops are enough for more than 100 days. Patients are supplied with twenty 5 ml bottles of 20% autologous serum and are advised to
store bottles in the freezer until use. They were advised to keep
bottles in current use in the refrigerator.
It should be noted that the contamination of autologous serum by
bacteria or fungi was not observed in our study. Since serum contains
many antibacterial agents such as IgG, lysozyme, and complement,
serum alone may have some bacteriostatic effects. This may be the
reason for the low rate of contamination of the serum bottles. This
offers the advantage of no additional preservatives which may cause
side effects. However, a more extensive study concerning the safety of
this procedure is required before a large scale clinical study can be undertaken.
Objective observations of rose bengal and fluorescein scores
dramatically improved in these patients. Since all patients have been
using conventional treatment before the study, the improvement can be
considered to be due to the effects of serum application. We speculate
that EGF and vitamin A are the major components responsible, but other
components in serum may also contribute in the amelioration of SS dry
eye. Our successful experience with ocular surface reconstruction in
ocular pemphigoid and Stevens-Johnson syndrome is also evidence that
autologous serum as a tear substitute is adequate for maintaining the
ocular surface epithelium.15 16 In addition to the
improvement in objective scores, many patients reported the relief of
discomfort and pain. The satisfaction rate of using autologous serum
was high, and many patients wished to continue serum drops after their second visit.
The beneficial effect of autologous serum may be multifactorial.
However, our simple experiment of the increased MUC-1 expression of
cultured conjunctival epithelium suggested a direct effect of the serum
on the ocular surface epithelium. Since rose bengal staining is
believed to be due to the lack of mucin, the increased mucin expression
can explain the dramatic effect on the improvement of vital staining in
the clinical investigation.
The drawbacks of this treatment are of course the necessity to obtain
blood from patients. Thus, the development of an ideal artificial tear
substitute containing these essential components would be ideal.
However, until such medication is available, the use of autologous
serum according to the protocol provided in this study may be of great
benefit for those in need.
This study was supported by grants from the Japanese Ministry
of Health and Welfare and the Oral Health Center of Tokyo Dental College.
We would like to express our gratitude to Ms Michi Nakauchi and Mr
Itsuo Yamamoto of the pharmaceutical department of Tokyo Dental College
for their efforts in supplying the autologous serum drops.
| 1.
|
Pflugfelder S,
Huang A,
Feuer W,
et al. Conjunctival cytologic features of primary Sjögren's syndrome.
Ophthalmology
1990;97:985-993[Medline].
|
| 2.
|
Tsubota K,
Toda I,
Yagi Y,
et al. Three different types of dry eye syndrome.
Cornea
1994;13:202-209[Medline].
|
| 3.
|
Tsubota K. SS dry eye and non-SS dry eye: what are the differences?
In:
Homma M,
Sugai S,
Tojo T,
Miyasaka N,
Akizuki M,
eds.
Sjögren's syndrome. Amsterdam: Kugler, 1994;27-31.
|
| 4.
|
Xu K,
Katagari S,
Takeuchi T,
et al. Biopsy of labial salivary glands and lacrimal glands in the diagnosis of Sjögren's syndrome.
J Rheumatol
1996;23:76-82[Medline].
|
| 5.
|
Tsubota K. The importance of the Schirmer test with nasal stimulation [letter].
Am J Ophthalmol
1991;111:106-108[Medline].
|
| 6.
|
Wilson S. Lacrimal gland epidermal growth factor production and the ocular surface.
Am J Ophthalmol
1991;111:763-765[Medline].
|
| 7.
|
Ubels J,
Loley K,
Rismondo V. Retinol secretion by the lacrimal gland.
Invest Ophthalmol Vis Sci
1986;27:1261-1269[Abstract/Free Full Text].
|
| 8.
|
Ohashi Y,
Motokura M,
Kinoshita Y,
et al. Presence of epidermal growth factor in human tears.
Invest Ophthalmol Vis Sci
1989;30:1879-1887[Abstract].
|
| 9.
|
Van Setten G,
Viinikka L,
Tervo T. Epidermal growth factor is a constant component of normal human tear fluid.
Graefes Arch Clin Exp Ophthalmol
1989;22:184-187.
|
| 10.
|
Van Setten G,
Macauley S,
Humphresy-Beher M,
et al. Detection of transforming growth factor-alpha mRNA and protein in rat lacrimal glands and characterization of transforming growth-alpha in human tears.
Invest Ophthalmol Vis Sci
1996;37:166-175[Abstract/Free Full Text].
|
| 11.
|
Van Settten G,
Tervo T,
Tervo K,
et al. Epidermal growth factor (EGF) in ocular fluids: presence, origin and therapeutical considerations.
Acta Ophthalmol
1992;202:54-59.
|
| 12.
| Tsubota K. Reflex tearing in dry eye not associated with
Sjögren's syndrome. In: Sullivan D, ed. Lacrimal
gland, tear film and dry eye syndromes 2. New York: Plenum
Press, 903-7.
|
| 13.
|
Fox R,
Chan R,
Michelson J,
et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca.
Arthritis Rheum
1984;27:459-461[Medline].
|
| 14.
|
Tsubota K.
New approaches in dry eye management: supplying missing tear components to the ocular surface epithelium. 1st Annual Meeting of Kyoto Cornea Club. Amsterdam: Kugler, 1997;1:27-32.
|
| 15.
|
Tsubota K,
Satake Y,
Shimazaki J. Treatment of severe dry eye.
Lancet
1996;348:123[Medline].
|
| 16.
|
Tsubota K,
Satake Y,
Ohyama M,
et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome.
Am J Ophthalmol
1996;122:38-52[Medline].
|
| 17.
|
Tsubota K,
Yamada M,
Urayama K. Spectacle side panels and moist inserts for the treatment of dry-eye patients.
Cornea
1994;13:197-201[Medline].
|
| 18.
|
Gupta A,
Monroy D,
Ji Z,
et al. Transforming growth factor beta-1 and beta-2 in human tear fluid.
Curr Eye Res
1996;15:605-614[Medline].
|
| 19.
|
Hirata Y,
Orth D. Epidermal growth factor (Urogastrone) in human fluids: size heterogeneity.
J Clin Endocrinol Metab
1979;48:673-679[Medline].
|
| 20.
|
Katsui G. Assay methods of vitamin A in blood and tissues.
Vitamins (Japanese)
1982;56:97-101.
|
| 21.
|
Tsubota K,
Xu K,
Fujihara T,
et al. Decreased reflex tearing is associated with lymphocyte infiltration in lacrimal and salivary glands.
Rheumatology
1996;23:313-320.
|
| 22.
|
Toda I,
Tsubota K. Practical double vital staining for ocular surface evaluation.
Cornea
1993;12:366-367[Medline].
|
| 23.
|
Tseng S. Staging of conjunctival squamous metaplasia by impression cytology.
Ophthalmology
1985;92:728-733[Medline].
|
| 24.
|
Hamano H,
Hori M,
Hamano T,
et al. A new method for measuring tears.
CLAO J
1983;9:281-289[Medline].
|
| 25.
|
Toda I,
Shimazaki J,
Tsubota K. Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis.
Ophthalmology
1995;102:302-309[Medline].
|
| 26.
|
Toda I,
Yagi Y,
Hata S,
et al. Excimer laser photorefractive keratectomy for patients with contact lens intolerance caused by dry eye.
Br J Ophthalmol
1996;80:604-609[Abstract/Free Full Text].
|
| 27.
|
Fox R,
Saito I. Criteria for diagnosis of Sjögren's syndrome.
Rheum Dis Clin North Am
1994;20:391-407[Medline].
|
| 28.
|
Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes.
CLAO J
1995;21:221-232[Medline].
|
| 29.
|
Hikichi T,
Yoshida A,
Tsubota K. Lymphocytic infiltration of the conjunctiva and the salivary gland in Sjögren's syndrome.
Arch Ophthalmol
1993;111:21-22[Medline].
|
| 30.
|
Lemp MA. Recent developments in dry eye management.
Ophthalmology
1987;94:1299-1305[Medline].
|
| 31.
|
Farris R. The dry eye: its mechanism and therapy, with evidence that contact lens is a cause.
CLAO J
1986;12:234-246[Medline].
|
| 32.
|
Tsubota K,
Nakamori K. Dry eyes and video display terminals.
N Engl J Med
1993;328:584[Free Full Text].
|
| 33.
|
Tsubota K. New approaches to dry-eye therapy.
Int Ophthalmol Clin
1994;34:115-128[Medline].
|
| 34.
|
Tsubota K,
Nakamori K. Effects of ocular surface area and blink rate on tear dynamics.
Arch Ophthalmol
1995;113:155-158[Abstract].
|
| 35.
|
Tsubota K,
Toda I,
Nakamori K. Poor illumination, VDTs and desiccated eyes.
Lancet
1996;347:768-769[Medline].
|
| 36.
|
Speek AJ,
van Agtmaal EJ,
Saowakontha S,
et al. Fluorometric determination of retinol in human tear fluid using high-performance liquid chromatography.
Curr Eye Res
1986;5:841-845[Medline].
|
| 37.
|
Tseng S,
Farazdaghi M,
Rider A. Conjunctival transdifferentiation induced by systemic vitamin A deficiency in vascularized rabbit corneas.
Invest Ophthalmol Vis Sci
1987;28:1497-1504[Abstract/Free Full Text].
|
| 38.
|
El-Ghorab M,
Capone A,
Underwood B,
et al. Response of ocular surface epithelium to corneal wounding in retinol-deficient rabbits.
Invest Ophthalmol Vis Sci
1988;29:1671-1676[Abstract].
|
| 39.
|
Wilson S,
Lloyd S,
Kennedy R. Basic fibroblast growth factor (FGFb) and epidermal growth factor (EGF) receptor messenger RNA production in human lacrimal gland.
Invest Ophthalmol Vis Sci
1991;32:2816-2820[Abstract/Free Full Text].
|